MA MPJE CORRECT FINAL 2026 QUESTIONS AND
ANSWERS SURE A+
Massachusetts, the inventory of controlled substances should be done every:
A) 1 year
B) 2 years
C) 3 years
D) 5 years - ✔✔(b) In Massachusetts, the inventory of controlled substances should be
done every two years, [Massachusetts Controlled Substance Act Chapter 94C: Section
15 and 21CFR1304.11(b),(c)].
Section 15: Persons registered to manufacture, distribute, dispense, or possess
controlled substances shall keep records and maintain inventories in conformance with
the record-keeping and inventory requirements of the Federal "Comprehensive Drug
Prevention and Control Act of 1970" or any amendment thereof, and the Federal Food,
Drug and Cosmetic Act, and with any additional rules or regulations promulgated by the
board of registration in pharmacy in the case of a retail drug business or wholesale
druggist or by the commissioner in all other cases.
Sec. 1304.11 Inventory requirements:
(a). Each inventory shall contain a complete and accurate record of all controlled
substances on hand on the date the inventory is taken, and shall be maintained in
written, typewritten, or printed form at the registered location.
(b). Initial inventory date. Every person required to keep records shall take an inventory
of all stocks of controlled substances on hand on the date he/she first engages in the
manufacture, distribution, or dispensing of controlled substances, in accordance with
paragraph (e) of this section as applicable.
,In the event a person commences business with no controlled substances on hand,
he/she shall record this fact as the initial inventory.
(c). Biennial inventory date. After the initial inventory is taken, the registrant shall take a
new inventory of all stocks of controlled substances on hand at least every two years.
The biennial inventory may be taken on any date which is within two years of the
previous biennial inventory date.
✔✔A pharmacist to whom a certificate of completion of CEUs has been issued shall
retain that certificate for a period of at least two years from the date of completion.
A) True
B) False - ✔✔(a) True, [247 CMR 4.07(2) and 247 CMR 4.08(1) AND Pharmacist FAQs:
http://www.mass.gov/eohhs/docs/dph/quality/boards/pharmacy/pharmacy-faq.pdf -
Question 13].
A pharmacist to whom a certificate of completion of CEUs has been issued shall retain
that certificate for a period of at least two years from the date of completion.
However, authorized providers shall maintain program records for a period of no less
than three years from the date of presentation of the program.
Authorized providers shall be responsible for retaining records of the program,
including:
(a). The name of each participant;
(b). the content of the program sponsored;
(c). the provider authorization number;
(d). the date of the continuing education program;
(e). the location of continuing education program;
(f). the name of the approved instructor; and
(g). an indication of whether the program was completed by home-study or other
mediated instruction.
✔✔In Massachusetts, inventory records must be maintained for a period of at least:
A) 1 year
,B) 2 years
C) 3 years
D) 4 years - ✔✔(b) According to Massachusetts State Pharmacy Law, inventory records
must be maintained for a period of at least two years from the date of such inventory or
record, [Massachusetts Controlled Substance Act Chapter 94C: Section 15 and
21CFR1304.04(a)].
Persons registered to manufacture, distribute, dispense, or possess controlled
substances shall keep records and maintain inventories in conformance with the record-
keeping and inventory requirements of the Federal ""Comprehensive Drug Prevention
and Control Act of 1970'' or any amendment thereof, and the Federal Food, Drug and
Cosmetic Act, and with any additional rules or regulations promulgated by the board of
registration in pharmacy in the case of a retail drug business or wholesale druggist or by
the commissioner in all other cases.
✔✔Collaborative practice agreement in the retail drug business setting may permit the
prescribing of schedule III through V controlled substances by a collaborating
pharmacist.
A) True
B) False - ✔✔(b) False, [M.G.L Chapter 112: Section 24B1/2(c)].
1. The collaborative practice agreement shall specifically reference each disease state
being co-managed. A patient shall be referred by a supervising physician to that
physician's collaborating pharmacist and shall be given notice of the collaboration and
shall consent to the collaboration.
2. No collaborative practice agreement in the retail drug business setting may permit the
prescribing of schedule II through V controlled substances.
3. A pharmacist in the retail setting, who has a collaborative practice agreement with a
supervising physician which specifically allows initial prescriptions for referred patients
of the supervising physician, may issue prescriptions for schedule VI controlled
substances.
4. Such prescriptions shall be for a patient diagnosis specified in the supervising
physician's individual referral of that patient.
5. A copy of the prescription shall be sent to the supervising physician within 24 hours.
✔✔The Board of Pharmacy may suspend or revoke a registration to dispense controlled
substances if the applicant:
, I. has furnished false or fraudulent material information in any application filed.
II. has had his federal registration suspended or revoked to dispense controlled
substances.
III. is, upon good cause, found to be unfit or unqualified to dispense controlled
substances.
A) I only
B) I and II only
C) II and III only
D) All of the above - ✔✔(d) All, [M.G.L Chapter 94C: Section 13(a)].
The board of registration in pharmacy in the case of a retail drug business or wholesale
druggist and the commissioner in all other cases may suspend or revoke a registration
to manufacture, distribute, dispense or possess a controlled substance, after a hearing
pursuant to the provisions of chapter thirty A upon a finding that the registrant:
(1). has furnished false or fraudulent material information in any application filed under
the provisions of this chapter;
(2). has been convicted under any state or federal law of any criminal violation relating
to his fitness to be registered under this chapter;
(3). has had his federal registration suspended or revoked to manufacture, distribute,
dispense, administer or possess controlled substances; or
(4). is, upon good cause, found to be unfit or unqualified to manufacture, distribute,
dispense, or possess any controlled substance.
✔✔A pharmacist receives a new prescription from a prescriber for compounding a
cream that is commercially available. What shall pharmacist do?
A) Fill the prescription
B) Do not fill the prescription - ✔✔(b) Do not fill the prescription, [FDA Compliance
Policy Guide Sec. 460.200 Pharmacy Compounding].
A pharmacist may not compound products that are commercially available, unless the
Board/FDA has given prior approval to compound a commercially available product that
is temporarily in short supply/unavailable.
ANSWERS SURE A+
Massachusetts, the inventory of controlled substances should be done every:
A) 1 year
B) 2 years
C) 3 years
D) 5 years - ✔✔(b) In Massachusetts, the inventory of controlled substances should be
done every two years, [Massachusetts Controlled Substance Act Chapter 94C: Section
15 and 21CFR1304.11(b),(c)].
Section 15: Persons registered to manufacture, distribute, dispense, or possess
controlled substances shall keep records and maintain inventories in conformance with
the record-keeping and inventory requirements of the Federal "Comprehensive Drug
Prevention and Control Act of 1970" or any amendment thereof, and the Federal Food,
Drug and Cosmetic Act, and with any additional rules or regulations promulgated by the
board of registration in pharmacy in the case of a retail drug business or wholesale
druggist or by the commissioner in all other cases.
Sec. 1304.11 Inventory requirements:
(a). Each inventory shall contain a complete and accurate record of all controlled
substances on hand on the date the inventory is taken, and shall be maintained in
written, typewritten, or printed form at the registered location.
(b). Initial inventory date. Every person required to keep records shall take an inventory
of all stocks of controlled substances on hand on the date he/she first engages in the
manufacture, distribution, or dispensing of controlled substances, in accordance with
paragraph (e) of this section as applicable.
,In the event a person commences business with no controlled substances on hand,
he/she shall record this fact as the initial inventory.
(c). Biennial inventory date. After the initial inventory is taken, the registrant shall take a
new inventory of all stocks of controlled substances on hand at least every two years.
The biennial inventory may be taken on any date which is within two years of the
previous biennial inventory date.
✔✔A pharmacist to whom a certificate of completion of CEUs has been issued shall
retain that certificate for a period of at least two years from the date of completion.
A) True
B) False - ✔✔(a) True, [247 CMR 4.07(2) and 247 CMR 4.08(1) AND Pharmacist FAQs:
http://www.mass.gov/eohhs/docs/dph/quality/boards/pharmacy/pharmacy-faq.pdf -
Question 13].
A pharmacist to whom a certificate of completion of CEUs has been issued shall retain
that certificate for a period of at least two years from the date of completion.
However, authorized providers shall maintain program records for a period of no less
than three years from the date of presentation of the program.
Authorized providers shall be responsible for retaining records of the program,
including:
(a). The name of each participant;
(b). the content of the program sponsored;
(c). the provider authorization number;
(d). the date of the continuing education program;
(e). the location of continuing education program;
(f). the name of the approved instructor; and
(g). an indication of whether the program was completed by home-study or other
mediated instruction.
✔✔In Massachusetts, inventory records must be maintained for a period of at least:
A) 1 year
,B) 2 years
C) 3 years
D) 4 years - ✔✔(b) According to Massachusetts State Pharmacy Law, inventory records
must be maintained for a period of at least two years from the date of such inventory or
record, [Massachusetts Controlled Substance Act Chapter 94C: Section 15 and
21CFR1304.04(a)].
Persons registered to manufacture, distribute, dispense, or possess controlled
substances shall keep records and maintain inventories in conformance with the record-
keeping and inventory requirements of the Federal ""Comprehensive Drug Prevention
and Control Act of 1970'' or any amendment thereof, and the Federal Food, Drug and
Cosmetic Act, and with any additional rules or regulations promulgated by the board of
registration in pharmacy in the case of a retail drug business or wholesale druggist or by
the commissioner in all other cases.
✔✔Collaborative practice agreement in the retail drug business setting may permit the
prescribing of schedule III through V controlled substances by a collaborating
pharmacist.
A) True
B) False - ✔✔(b) False, [M.G.L Chapter 112: Section 24B1/2(c)].
1. The collaborative practice agreement shall specifically reference each disease state
being co-managed. A patient shall be referred by a supervising physician to that
physician's collaborating pharmacist and shall be given notice of the collaboration and
shall consent to the collaboration.
2. No collaborative practice agreement in the retail drug business setting may permit the
prescribing of schedule II through V controlled substances.
3. A pharmacist in the retail setting, who has a collaborative practice agreement with a
supervising physician which specifically allows initial prescriptions for referred patients
of the supervising physician, may issue prescriptions for schedule VI controlled
substances.
4. Such prescriptions shall be for a patient diagnosis specified in the supervising
physician's individual referral of that patient.
5. A copy of the prescription shall be sent to the supervising physician within 24 hours.
✔✔The Board of Pharmacy may suspend or revoke a registration to dispense controlled
substances if the applicant:
, I. has furnished false or fraudulent material information in any application filed.
II. has had his federal registration suspended or revoked to dispense controlled
substances.
III. is, upon good cause, found to be unfit or unqualified to dispense controlled
substances.
A) I only
B) I and II only
C) II and III only
D) All of the above - ✔✔(d) All, [M.G.L Chapter 94C: Section 13(a)].
The board of registration in pharmacy in the case of a retail drug business or wholesale
druggist and the commissioner in all other cases may suspend or revoke a registration
to manufacture, distribute, dispense or possess a controlled substance, after a hearing
pursuant to the provisions of chapter thirty A upon a finding that the registrant:
(1). has furnished false or fraudulent material information in any application filed under
the provisions of this chapter;
(2). has been convicted under any state or federal law of any criminal violation relating
to his fitness to be registered under this chapter;
(3). has had his federal registration suspended or revoked to manufacture, distribute,
dispense, administer or possess controlled substances; or
(4). is, upon good cause, found to be unfit or unqualified to manufacture, distribute,
dispense, or possess any controlled substance.
✔✔A pharmacist receives a new prescription from a prescriber for compounding a
cream that is commercially available. What shall pharmacist do?
A) Fill the prescription
B) Do not fill the prescription - ✔✔(b) Do not fill the prescription, [FDA Compliance
Policy Guide Sec. 460.200 Pharmacy Compounding].
A pharmacist may not compound products that are commercially available, unless the
Board/FDA has given prior approval to compound a commercially available product that
is temporarily in short supply/unavailable.
